Electroporation Instruments Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-26　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 1.7 Bn
2033 年預估規模: USD 4.2 Bn
年複合成長率 CAGR: 9.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Electroporation Instruments Market, By Product Type (Systems and Accessories (Electrodes, Cuvettes, Chambers, Kits, Others)), By Application (Protein Production, Drug Delivery, Biomedical Research, Gene Therapy, Ablation (Oncology, Cardiology, Others), Others), By Mode (In-Vitro/Clinical and In-Vivo), By End user (Biopharmaceutical, Companies, Hospitals, Research & Academic, Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Electroporation is a useful molecular biology technique that allows for non-chemical transformation of bacteria and yeasts as well as transfection of tissue culture cells (e.g. mammalian cells). Electroporation systems deliver short bursts of a high-intensity electric field to cells. The electrical field makes the cell membrane more permeable. As a result, chemicals such as drugs and genetic material can pass through the cell membrane, which would otherwise be impermeable. Due to its ease of use and efficacy, electroporation is a popular method for introducing foreign genes into target cells. In addition to direct gene introduction, electroporation allows for the direct transfer of plasmids between cells or species—for instance, from bacteria to yeast. Extensive research is ongoing on the use of electroporation to deliver medicines and vaccines directly to the cells of living organisms. Electroporation systems are commonly used for the treatment of cancer through vaccine delivery, gene delivery or drug delivery that is electrochemotherapy, for instance bleomycin Vaccine delivery can also be used for treatment of infectious disease such as Human immunodeficiency virus (HIV). Market Dynamics Key players operating in the global electroporation instruments market are focusing on growth strategies such as rebranding and agreements which is expected to drive the market growth during the forecast period. For instance, The Company is now operating as Eppendorf SE with immediate effect. Eppendorf AG was restructured into a European Company (Societas Europaea, SE) under the name Eppendorf SE, effective October 19, 2021. This change of legal form to an SE does not affect any existing business relationships with their partners; existing contractual relationships in particular continue unchanged. Moreover, On July 15, 2022, MaxCyte, Inc. had announced the Strategic Platform License (SPL) signed with LG Chem Ltd., a global diversified chemical company .Under the terms of the agreement, LG Chem will receive non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. In return, MaxCyte is entitled to platform license fees and program-related revenues. Key features of the study • This report provides in-depth analysis of the global electroporation instruments market, and provides market size (USD Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026 – 2033). • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players. • The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global electroporation instruments market. • The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global electroporation instruments market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global electroporation instruments market. Market Segmentation • By Product Type o Systems o Accessories  Electrodes  Cuvettes  Chambers  Kits  Others • By Application o Protein Production o Drug Delivery o Biomedical Research o Gene Therapy o Ablation  Oncology  Cardiology  Others o Others • By Mode o In-Vitro/Clinical o In-Vivo • By End user o Biopharmaceutical Companies o Hospitals o Research & Academic o Institutes o Others • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Bio-Rad Laboratories, Inc o Thermo Fisher Scientific Inc. o BTX ( a division of Harvard Bioscience) o Celetrix, LLC. o Gamma Biosciences o Merck KgaA o Eppendorf SE o MaxCyte, Inc. o BEX CO.,LTD. o Lonza o Altogen Biosystems o Ala Scientific Instruments, Inc. o BioEra Life Sciences Pvt. Ltd. o Ichor Medical Systems

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Application  Market Snapshot, By Mode  Market Snapshot, By End User  Market Snapshot, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Opportunity o Impact Analysis o Overview -Application of Electroporation in various treatments o Market Trends o Key Highlights o Regulatory Scenario o PEST Analysis o Porter’s Analysis o Technological Advancements 4. Global Electroporation Instruments Market, By Product Type, 2026-2033 (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Systems  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Accessories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Electrodes o Cuvettes o Chambers o Kits o Others 5. Global Electroporation Instruments Market, By Application, 2026-2033 (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Protein Production  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Drug Delivery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Biomedical Research  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Gene Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ablation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Oncology o Cardiology o Others o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Electroporation Instruments Market, By End User, 2026-2033 (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o In-vitro/clinical  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o In-vivo  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Electroporation Instruments Market, By End User, 2026-2033 (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Biopharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Research & Academic Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Electroporation Instruments Market By Region, 2026-2033 (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o Germany o U.K. o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021-2033, (USD Bn) o South Africa o North Africa o Central Africa 9. Company Profiles o Bio-Rad Laboratories, Inc.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Thermo Fisher Scientific Inc.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o BTX ( a division of Harvard Bioscience)  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Celetrix, LLC.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Gamma Biosciences  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Merck KgaA  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Eppendorf SE  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o MaxCyte, Inc.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o BEX CO.,LTD.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Lonza  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Altogen Biosystems  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Ala Scientific Instruments, Inc.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o BioEra Life Sciences Pvt. Ltd.  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies o Ichor Medical Systems  Company Highlights  Products Portfolio  Key Highlights  Financial Performance  Strategies 10. Section o Research Methodology o About Us and Services

提及公司

Bio-Rad Laboratories, IncThermo Fisher Scientific Inc.BTX ( a division of Harvard Bioscience)Celetrix, LLC.Gamma BiosciencesMerck KgaAEppendorf SEMaxCyte, Inc.BEX CO.,LTD.LonzaAltogen BiosystemsAla Scientific Instruments, Inc.BioEra Life Sciences Pvt. Ltd.Ichor Medical Systems

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們